1887

Journal of Medical Microbiology logo

Volume 72, Issue 12

Meta-analysis of sputum microbiome studies identifies airway disease-specific taxonomic and functional signatures No Access

Abstract

Studying taxonomic and functional signatures of respiratory microbiomes provide a better understanding of airway diseases.

. Several human airway metagenomics studies have identified taxonomic and functional features restricted to a single disease condition and the findings are not comparable across airway diseases due to use of different samples, NGS platforms, and bioinformatics databases and tools.

To study the microbial taxonomic and functional components of sputum microbiome across airway diseases and healthy smokers.

Here, 57 whole metagenome shotgun sequencing (WMSS) runs coming from the sputum of five airway diseases: asthma, bronchiectasis, chronic obstructive pulmonary diseases (COPD), cystic fibrosis (CF), tuberculosis (TB), and healthy smokers as the control were reanalysed using a common WMSS analysis pipeline.

Shannon’s index (alpha diversity) of the healthy smoker group was the highest among all. The beta diversity showed that the sputum microbiome is distinct in major airway diseases such as asthma, COPD and cystic fibrosis. The microbial composition based on differential analysis showed that there are specific markers for each airway disease like as a marker for COPD and as a marker cystic fibrosis. Pathways and metabolites identified from the sputum microbiome of these five diseases and healthy smokers also show specific markers. ‘ppGpp biosynthesis’ and ‘purine ribonucleosides degradation’ pathways were identified as differential markers for bronchiectasis and COPD. In this meta-analysis, besides bacteria kingdom, was detected in asthma and COPD, and Roseolovirus human betaherpesvirus 7 was detected in COPD. Our analysis showed that the majority of the gene families specific to the drug-resistant associated genes were detected from opportunistic pathogens across all the groups.

In summary, the specific species in the sputum of airway diseases along with the microbial features like specific gene families, pathways, and metabolites were identified which can be explored for better diagnosis and therapy.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antibiotic resistance genes , asthma , COPD , cystic fibrosis , metagenomics , sputum microbiome and tuberculosis
© 2022 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001617
2022-12-16
2024-04-24
Loading full text...

Full text loading...

References

  1. Dickson RP, Erb-Downward JR, Martinez FJ, Huffnagle GB. The microbiome and the respiratory tract. Annu Rev Physiol 2016; 78:481–504 [View Article]
     [Google Scholar]
  2. Dickson RP, Schultz MJ, van der Poll T, Schouten LR, Falkowski NR et al. Lung microbiota predict clinical outcomes in critically Ill patients. Am J Respir Crit Care Med 2020; 201:555–563 [View Article]
     [Google Scholar]
  3. Cheng C, Wang Z, Wang J, Ding C, Sun C et al. Characterization of the lung microbiome and exploration of potential bacterial biomarkers for lung cancer. Transl Lung Cancer Res 2020; 9:693–704 [View Article]
     [Google Scholar]
  4. Pettigrew MM, Tanner W, Harris AD. The lung microbiome and pneumonia. J Infect Dis 2021; 223:S241–S245 [View Article]
     [Google Scholar]
  5. Chang D, Dela Cruz CS, Sharma L. Challenges in understanding lung microbiome: it is NOT like the gut microbiome. Respirology 2020; 25:244–245 [View Article]
     [Google Scholar]
  6. Carney SM, Clemente JC, Cox MJ, Dickson RP, Huang YJ et al. Methods in lung microbiome research. Am J Respir Cell Mol Biol 2020; 62:283–299 [View Article]
     [Google Scholar]
  7. Pu CY, Seshadri M, Manuballa S, Yendamuri S. The oral microbiome and lung diseases. Curr Oral Health Rep 2020; 7:79–86 [View Article]
     [Google Scholar]
  8. Salisbury ML, Han MK, Dickson RP, Molyneaux PL. Microbiome in interstitial lung disease: from pathogenesis to treatment target. Curr Opin Pulm Med 2017; 23:404–410 [View Article] [PubMed]
     [Google Scholar]
  9. Amati F, Stainer A, Mantero M, Gramegna A, Simonetta E et al. Lung microbiome in idiopathic pulmonary fibrosis and other interstitial lung diseases. Int J Mol Sci 2022; 23:977 [View Article]
     [Google Scholar]
  10. Faner R, Sibila O, Agustí A, Bernasconi E, Chalmers JD et al. The microbiome in respiratory medicine: current challenges and future perspectives. Eur Respir J 2017; 49:1602086 [View Article]
     [Google Scholar]
  11. Dubourg G, Abat C, Rolain J-M, Raoult D. Correlation between sputum and bronchoalveolar lavage fluid cultures. J Clin Microbiol 2015; 53:994–996 [View Article] [PubMed]
     [Google Scholar]
  12. Quince C, Walker AW, Simpson JT, Loman NJ, Segata N. Shotgun metagenomics, from sampling to analysis. Nat Biotechnol 2017; 35:833–844 [View Article] [PubMed]
     [Google Scholar]
  13. Ranjan R, Rani A, Metwally A, McGee HS, Perkins DL. Analysis of the microbiome: advantages of whole genome shotgun versus 16S amplicon sequencing. Biochem Biophys Res Commun 2016; 469:967–977 [View Article]
     [Google Scholar]
  14. Durazzi F, Sala C, Castellani G, Manfreda G, Remondini D et al. Comparison between 16S rRNA and shotgun sequencing data for the taxonomic characterization of the gut microbiota. Sci Rep 2021; 11:3030 [View Article]
     [Google Scholar]
  15. Gupta S, Shariff M, Chaturvedi G, Sharma A, Goel N et al. Comparative analysis of the alveolar microbiome in COPD, ECOPD, Sarcoidosis, and ILD patients to identify respiratory illnesses specific microbial signatures. Sci Rep 2021; 11:3963 [View Article]
     [Google Scholar]
  16. Gibson PG, Yang IA, Upham JW, Reynolds PN, Hodge S et al. Efficacy of azithromycin in severe asthma from the AMAZES randomised trial. ERJ Open Res 2019; 5:00056–02019 [View Article] [PubMed]
     [Google Scholar]
  17. Taccetti G, Francalanci M, Pizzamiglio G, Messore B, Carnovale V et al. Cystic fibrosis: recent insights into inhaled antibiotic treatment and future perspectives. Antibiotics 2021; 10:338 [View Article]
     [Google Scholar]
  18. Zhang H-L, Tan M, Qiu A-M, Tao Z, Wang C-H. Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis. BMC Pulm Med 2017; 17:196 [View Article]
     [Google Scholar]
  19. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL et al. Executive summary: official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis 2016; 63:853–867 [View Article]
     [Google Scholar]
  20. Langdon A, Crook N, Dantas G. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med 2016; 8:39 [View Article]
     [Google Scholar]
  21. Ramirez J, Guarner F, Bustos Fernandez L, Maruy A, Sdepanian VL et al. Antibiotics as major disruptors of gut microbiota. Front Cell Infect Microbiol 2020; 10:572912 [View Article]
     [Google Scholar]
  22. McInnes RS, McCallum GE, Lamberte LE, van Schaik W. Horizontal transfer of antibiotic resistance genes in the human gut microbiome. Curr Opin Microbiol 2020; 53:35–43 [View Article] [PubMed]
     [Google Scholar]
  23. Bag S, Ghosh TS, Banerjee S, Mehta O, Verma J et al. Molecular insights into antimicrobial resistance traits of commensal human gut microbiota. Microb Ecol 2019; 77:546–557 [View Article]
     [Google Scholar]
  24. Mitchell AL, Almeida A, Beracochea M, Boland M, Burgin J et al. MGnify: the microbiome analysis resource in 2020. Nucleic Acids Res 2020; 48:D570–D578 [View Article]
     [Google Scholar]
  25. Taylor SL, Leong LEX, Mobegi FM, Choo JM, Wesselingh S et al. Long-term azithromycin reduces Haemophilus influenzae and increases antibiotic resistance in severe asthma. Am J Respir Crit Care Med 2019; 200:309–317 [View Article]
     [Google Scholar]
  26. Taylor SL, Leong LEX, Mobegi FM, Choo JM, Burr LD et al. Understanding the impact of antibiotic therapies on the respiratory tract resistome: a novel pooled-template metagenomic sequencing strategy. Multidiscip Respir Med 2018; 13:30 [View Article]
     [Google Scholar]
  27. Cameron SJS, Lewis KE, Huws SA, Lin W, Hegarty MJ et al. Metagenomic sequencing of the chronic obstructive pulmonary disease upper bronchial tract microbiome reveals functional changes associated with disease severity. PLoS One 2016; 11:e0149095 [View Article]
     [Google Scholar]
  28. Dmitrijeva M, Kahlert CR, Feigelman R, Kleiner RL, Nolte O et al. Strain-resolved dynamics of the lung microbiome in patients with cystic fibrosis. mBio 2021; 12:e02863-20 [View Article]
     [Google Scholar]
  29. Doughty EL, Sergeant MJ, Adetifa I, Antonio M, Pallen MJ. Culture-independent detection and characterisation of Mycobacterium tuberculosis and M. africanum in sputum samples using shotgun metagenomics on a benchtop sequencer. PeerJ 2014; 2:e585 [View Article]
     [Google Scholar]
  30. Leo S, Gaïa N, Ruppé E, Emonet S, Girard M et al. Detection of bacterial pathogens from broncho-alveolar lavage by next-generation sequencing. Int J Mol Sci 2017; 18:2011 [View Article]
     [Google Scholar]
  31. Andrews S. FastQC: a quality control tool for high throughput sequence data; 2021Retrieved 20 July https://www.bioinformatics.babraham.ac.uk/projects/fastqc
  32. Krueger F, James F, Ewels P, Afyounian E, Schuster-Boeckler B. FelixKrueger/TrimGalore: v0.6.7 - DOI via Zenodo (0.6.7). Zenodo; 2021Retrieved 28 July https://zenodo.org/record/5127899
  33. Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol 2019; 20:257 [View Article]
     [Google Scholar]
  34. Dabdoub S. kraken-biom: enabling interoperative format conversion for Kraken results (Version 1.2) [Software]; 2016 https://github.com/smdabdoub/kraken-biom
  35. Franzosa EA, McIver LJ, Rahnavard G, Thompson LR, Schirmer M et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat Methods 2018; 15:962–968 [View Article] [PubMed]
     [Google Scholar]
  36. McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 2013; 8:e61217 [View Article]
     [Google Scholar]
  37. Breitwieser FP, Salzberg SL. Pavian: interactive analysis of metagenomics data for microbiome studies and pathogen identification. Bioinformatics 2020; 36:1303–1304 [View Article] [PubMed]
     [Google Scholar]
  38. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011; 12:R60 [View Article]
     [Google Scholar]
  39. Yang yiluheihei/microbiomeMarker: microbiomeMarker 0.0.1 (v0.0.1). Zenodo; 2020Retrieved 21 April https://zenodo.org/record/3749415
  40. Suzek BE, Wang Y, Huang H, McGarvey PB, Wu CH et al. UniRef clusters: a comprehensive and scalable alternative for improving sequence similarity searches. Bioinformatics 2015; 31:926–932 [View Article] [PubMed]
     [Google Scholar]
  41. Devlin JC, Battaglia T, Blaser MJ, Ruggles KV. WHAM!: a web-based visualization suite for user-defined analysis of metagenomic shotgun sequencing data. BMC Genomics 2018; 19:493 [View Article] [PubMed]
     [Google Scholar]
  42. Mallick H, Franzosa EA, Mclver LJ, Banerjee S, Sirota-Madi A et al. Predictive metabolomic profiling of microbial communities using amplicon or metagenomic sequences. Nat Commun 2019; 10:3136 [View Article]
     [Google Scholar]
  43. Ghosh A, N S, Saha S. Survey of drug resistance associated gene mutations in Mycobacterium tuberculosis, ESKAPE and other bacterial species. Sci Rep 2020; 10:8957 [View Article]
     [Google Scholar]
  44. Firmida MC, Marques EA, Leão RS, Pereira RHV, Rodrigues ERA et al. Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: case reports. Respir Med Case Rep 2017; 20:98–103 [View Article]
     [Google Scholar]
  45. Stelzmueller I, Biebl M, Wiesmayr S, Eller M, Hoeller E et al. Ralstonia pickettii-innocent bystander or a potential threat?. Clin Microbiol Infect 2006; 12:99–101 [View Article] [PubMed]
     [Google Scholar]
  46. Laurence M, Hatzis C, Brash DE. Common contaminants in next-generation sequencing that hinder discovery of low-abundance microbes. PLoS One 2014; 9:e97876 [View Article]
     [Google Scholar]
  47. Aldhahrani A, Verdon B, Ward C, Pearson J. Effects of bile acids on human airway epithelial cells: implications for aerodigestive diseases. ERJ Open Res 2017; 3:00107–02016 [View Article] [PubMed]
     [Google Scholar]
  48. Hong B-Y, Paulson JN, Stine OC, Weinstock GM, Cervantes JL. Meta-analysis of the lung microbiota in pulmonary tuberculosis. Tuberculosis 2018; 109:102–108 [View Article]
     [Google Scholar]
  49. Najafi S, Abedini F, Azimzadeh Jamalkandi S, Shariati P, Ahmadi A et al. The composition of lung microbiome in lung cancer: a systematic review and meta-analysis. BMC Microbiol 2021; 21:315 [View Article]
     [Google Scholar]
  50. Duvallet C, Gibbons SM, Gurry T, Irizarry RA, Alm EJ. Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nat Commun 2017; 8:1784 [View Article]
     [Google Scholar]
  51. Armour CR, Nayfach S, Pollard KS, Sharpton TJ. A metagenomic meta-analysis reveals functional signatures of health and disease in the human gut microbiome. mSystems 2019; 4:e00332-18 [View Article]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001617
Loading
Meta-analysis of sputum microbiome studies identifies airway disease-specific taxonomic and functional signatures
J. Med. Microbiol. 72, 001617 (2024); https://doi.org/10.1099/jmm.0.001617
/content/journal/jmm/10.1099/jmm.0.001617
/content/journal/jmm/10.1099/jmm.0.001617
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error